| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000024021 |
| Receipt No. | R000027663 |
| Official scientific title of the study | A fully-automated rapid detection system for detecting PNPLA3 (rs738409) single nucleotide polymorphisms associated with the prognosis of fatty liver |
| Date of disclosure of the study information | 2016/09/13 |
| Last modified on | 2016/09/12 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A fully-automated rapid detection system for detecting PNPLA3 (rs738409) single nucleotide polymorphisms associated with the prognosis of fatty liver | |
| Title of the study (Brief title) | A fully-automated rapid detection system for detecting PNPLA3 (rs738409) single nucleotide polymorphisms associated with the prognosis of fatty liver | |
| Region |
|
|
| Condition | ||
| Condition | fatty liver | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | PNPLA3 (patatin-like phospholipase domain-containing 3) gene localized on human chromosome 22 encodes a protein known as adiponutrin, which is expressed in both adipocytes and hepatocytes. PNPLA3 protein affects energy mobilization and the storage of lipid droplets, because it has lipase activity against triglycerides. Recent studies have shown that the PNPLA3 SNPs are associated with the natural course of nonalcoholic fatty liver disease and alcoholic liver disease. The i-densyTM (Arkray, Inc.), which is based on the quenching probe (QP) method, automatically detects target genes in blood samples within 90 min. The aim of current study was to compare the utility of QP method with that of conventional direct sequencing for detecting SNPs in the PNPLA3 gene. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Consistency between the Quenching probe method and the Direct sequence method |
| Key secondary outcomes | |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with fatty liver disease | |||
| Key exclusion criteria | patient who cannot declare informed-consent | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Yasunori Kawaguchi |
| Organization | Saga-Ken Medical Centre Koseikan |
| Division name | Department of Hepatobiliary and Pancreatology |
| Address | 400 Nakabaru, Kase-machi, Saga-shi, Saga 840-8571, Japan |
| TEL | 0952-24-2171 |
| kawaguy222@gmail.com | |
| Public contact | |
| Name of contact person | Yasunori Kawaguchi |
| Organization | Saga-Ken Medical Centre Koseikan |
| Division name | Department of Hepatobiliary and Pancreatology |
| Address | 400 Nakabaru, Kase-machi, Saga-shi, Saga 840-8571, Japan |
| TEL | 0952-24-2171 |
| Homepage URL | |
| kawaguy222@gmail.com | |
| Sponsor | |
| Institute | Saga-Ken Medical Centre Koseikan |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Saga-Ken Medical Centre Koseikan |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The current study was performed to compare the utility of Quenching probe method with that of conventional direct sequencing for detecting the PNPLA3 gene SNPs in patients' blood sample. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027663 |